VELKA Hellas SA was founded in 1970 as a Greek pharmaceutical company and joined the RAFARM SA Group in 1993, while in June 2014 VELKA Hellas SA started its commercial activities.

The aim of the RAFARM SA Group, from its inception until today, remains the production of high quality pharmaceutical products, providing access of all patients to appropriate treatment in affordable prices.

The aim of VELKA Hellas SA, throughout the operating framework of RAFARM SA Group, is to be considered as a Greek interest pharmaceutical company of multinational orientation with:

• Innovative medicines

• Total quality services

• Solid corporate position, recognizable by all stakeholders in the health sector

• Wide social contribution

• Partnerships with multinational companies and representation of important medicines